Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
Clinical trial NCT04676633 · COMPLETED
Trial details
- NCT number
- NCT04676633
- Sponsor
- Sirnaomics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2023-01-13
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.